Family Medicine · Hemet, CA
NPI
1699702142
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
903 E Devonshire Ave, #f
Hemet, CA, 92543
Phone (951) 929-1611
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
896 services
Medicare patients, 2024
168
Average age 72
Drug cost, 2024
$2.2M
17,225 prescriptions
Company payments, 2025
$2,120
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hadia Ashraf was code 99215 (office e&m - established), 425 times for 151 patients. In total Hadia Ashraf billed 896 services in 24 codes, and Medicare paid $92K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 425 | 151 | $133.40 | $57K |
| 99497 Care Management/Coordination | Office | 112 | 110 | $61.60 | $6,899 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 104 | 104 | $133.15 | $14K |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 38 | 19 | $81.42 | $3,094 |
| 96372 Injection Administration | Office | 32 | 14 | $9.99 | $320 |
| G0008 Administration of influenza virus vaccine | Office | 31 | 30 | $29.40 | $911 |
| 90658 Vaccine Product | Office | 27 | 27 | $21.42 | $578 |
| 99214 Office E&M - Established | Office | 19 | 17 | $83.43 | $1,585 |
| 99205 Office E&M - New | Office | 17 | 17 | $123.85 | $2,106 |
| 99213 Office E&M - Established | Office | 16 | 13 | $65.03 | $1,040 |
By year: 2022 $130K for 1,364 services; 2023 $101K for 1,012 services; 2024 $92K for 896 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hadia Ashraf prescribed most often to Medicare patients was Amlodipine Besylate, with 728 prescriptions and refills. In total Hadia Ashraf wrote 17,225 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 728 | 1,927 | 198 | $5,035 |
| Rosuvastatin Calcium Generic | 702 | 1,956 | 216 | $12K |
| Atorvastatin Calcium Generic | 602 | 1,505 | 161 | $6,608 |
| Levothyroxine Sodium Generic | 600 | 1,569 | 148 | $8,126 |
| Losartan Potassium Generic | 589 | 1,662 | 186 | $7,381 |
| Metformin Hcl Generic | 567 | 1,515 | 167 | $5,349 |
| Gabapentin Generic | 497 | 1,050 | 141 | $7,651 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 397 | 399 | 51 | $4,319 |
| Omeprazole Generic | 370 | 881 | 109 | $4,936 |
| Lisinopril Generic | 343 | 868 | 93 | $2,707 |
| Escitalopram Oxalate Generic | 320 | 742 | 89 | $3,474 |
| Pantoprazole Sodium Generic | 270 | 628 | 82 | $3,747 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 269 | 305 | 58 | $188K |
| Fluticasone Propionate Generic | 223 | 327 | 105 | $4,206 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 218 | 264 | 67 | $9,382 |
Brand drugs: 2,800 claims; generic drugs: 14,238 claims; opioid claims: 710.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hadia Ashraf $2,120 ($2,120 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $361.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 10 | $361 |
| Novo Nordisk Inc NVO | 17 | $212 |
| Lilly USA, LLC LLY | 11 | $211 |
| Abbott Laboratories ABT | 4 | $208 |
| Corcept Therapeutics CORT | 15 | $206 |
| Lundbeck LLC | 10 | $160 |
| GlaxoSmithKline, LLC. GSK | 5 | $117 |
| Ardelyx, Inc. ARDX | 3 | $90.99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $83.83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.